Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK
The oral GLP-1 treatment is now available for eligible adults by private prescription as Lilly seeks NHS access in England.
- On Monday, Eli Lilly launched Foundayo, an oral weight-loss and diabetes medication, in the UK via private prescription. This marks the drug's first European market availability.
- The Medicines and Healthcare products Regulatory Agency authorized the drug on August 10, 2026, enabling commercial availability. Foundayo is an oral GLP-1 receptor agonist offering patients an injectable-free alternative.
- Foundayo is licensed for adults with a Body Mass Index of 30 or higher, or those with a BMI between 27 and 30 with weight-related conditions. Pricing is expected between £100 and £120, lower than Mounjaro's £330 monthly cost.
- Lilly is working with the National Institute for Health and Care Excellence on an assessment for potential NHS rollout. Pharmacists warn patients to access treatments only through safe, regulated pharmacies to avoid counterfeit versions.
- This launch follows Novo Nordisk's Wegovy approval in June, the first oral GLP-1 pill cleared in Britain. Foundayo remains under review in the European Union and is currently only commercially available in the US and UAE besides the UK.
16 Articles
16 Articles
Eli Lilly launched her Foundayo weight loss pill in the UK, making the country the first in Europe to offer oral treatment. Exclusive material for subscribers. To have full access, access the link of the material and register.
Britain first in Europe to launch daily weight-loss pill
Britain has become the first nation in Europe to make a new daily weight-loss tablet available to patients, marking another milestone in the country's embrace of GLP-1 treatments. Foundayo, the brand name for orforglipron, is manufactured by the American pharmaceutical giant Eli Lilly and can now be obtained from certain pharmacies across the United Kingdom.The Medicines and Healthcare products Regulatory Agency granted authorisation for the dru…
A new daily pill used to treat type 2 diabetes and aid weight loss has gone on sale in pharmacies in the UK. Offering an alternative for patients who prefer not to receive injections, the drug has prompted authorities to issue warnings about the risk of counterfeit and unlicensed products.
New weight loss pill launches in UK's pharmacies with key difference
Coverage Details
Bias Distribution
- 40% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
